Untitled Page

Remus Pharmaceuticals Ltd. Income Statement

Industry	Phar	BSE Code		Face Value	10.00
Chairman		NSE Code		Market Lot	100
Group	Not Applicable	ISIN No	INE0O5T01011	Book Closure	14/11/2025

You can view the Income statement for the last 5 years.

(Rs. in Crs.)

Particulars	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	78.21	63.50	45.03	24.72	18.42
Other Operating Revenues	0.95	0.00	0.00	0.00	0.00
Total Operating Revenues	79.16	63.50	45.03	24.72	18.42

Other Income	2.91	3.69	1.58	0.72	0.81
Total Revenue	82.07	67.19	46.60	25.44	19.22

EXPENSES
Purchase Of Stock-In Trade	35.27	29.21	20.14	12.71	12.21
Changes In Inventories Of FG,WIP And Stock-In Trade	-0.23	-1.38	1.30	-0.44	-0.71
Employee Benefit Expenses	9.17	6.56	5.47	3.49	3.00
Finance Costs	0.38	0.32	0.23	0.09	0.04
Depreciation And Amortisation Expenses	1.87	0.90	0.48	0.15	0.18
Other Expenses	8.97	9.06	7.57	4.89	3.17
Total Expenses	55.43	44.67	35.19	20.89	17.87

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	26.64	22.52	11.41	4.55	1.36

Profit/Loss Before Tax	26.64	22.52	11.41	4.55	1.36

Tax Expenses-Continued Operations
Current Tax	6.67	6.45	3.00	1.19	0.37
Deferred Tax	0.07	-0.71	-0.09	-0.03	-0.03
Tax For Earlier Years	0.00	-0.03	0.00	0.00	0.00
Total Tax Expenses	6.74	5.71	2.91	1.16	0.33
Profit/Loss After Tax And Before ExtraOrdinary Items	19.90	16.82	8.50	3.39	1.03

Profit/Loss From Continuing Operations	19.90	16.82	8.50	3.39	1.03

Profit/Loss For The Period	19.90	16.82	8.50	3.39	1.03

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	33.75	118.72	83.24	33.86	10.26
Diluted EPS (Rs.)	33.75	118.72	83.24	33.86	10.26

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	1.18	0.59	0.00	0.00	0.00
Equity Dividend Rate (%)	15.00	60.00	20.00	0.00	0.00

Company Info

Type first few letters

*